The study quality was evaluated using the Cochrane Collaboration risk of bias tool for RCTs. The tool included seven domains (such as random sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessment, incomplete data, selective reporting, and other bias) of assessment and are classified as low, unclear, or high risk. Due to the inclusion of limited studies, the publication bias was not assessed by funnel plot but done by Egger's test. The validity of the study was assessed by one of the authors (Weihong Wang) by using the GRADEpro GDT approach (https://gdt. http://gradepro.org/app) to summarize quality of the evidence.

Note: The content above has been extracted from a research article, so it may not display correctly.



Q&A
Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.



We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.